AFP and hepatocellular carcinoma: Serum miR‐765 was significantly increased in patients with AFP‐HCC (183.1 ± 22.6) compared with cirrhosis (144.0 ± 18.9) and controls (142.9 ± 19.6, P < .05, Figure 2D).